Stuart Harris
Internal Medicine · Miami, FLNPI 1013315902
Payments from drug & device makers
What this record shows
That places this record below the midpoint for internal medicine clinicians in FL, where the typical reported total is $316.
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
$616,504in research payments, 2019–2025
Across 10 payments — averaging $61,650 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Assertio Therapeutics, Inc.$551K
- Eagle Pharmaceuticals, Inc.$62K
- Pfizer$3K
How this compares
$0 in reported general payments places this provider in the 5th percentile of 8,530 internal medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Olmesartan Medoxomil | 12 | $316 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Miami
- Haytham ElgammalMiami$2.2M
- Richard AguilarMiami$239K
- Maria Delgado LelievreMiami$80K
- Marlow HernandezMiami$58K
- Steven CohnMiami$47K
- Joseph PiperatoMiami$45K
- Simon AbelsonMiami$44K
- Joel Brooks TamayoMiami$42K
- Keith RubinFort Lauderdale$2M
- Michael SensionFort Lauderdale$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.